Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Psychopharmacology Bulletin
|
January 1, 1987
Clonazepam in the treatment of panic disorder and agoraphobia
M H Pollack, J F Rosenbaum, G E Tesar, et al.
Diabetes
|
December 1, 1970
Diabetes incidence: a two-year follow-up of 10,000 men in a survey of ischemic heart disease in Israel
J B Herman, J H Medalie, H A Kahn, et al.
Journal of Chronic Diseases
|
February 1, 1971
Factors related to diabetes incidence: a multivariate analysis of two years observation on 10,000 men. The Israel Ischemic Heart Disease Study
H A Kahn, J B Herman, J H Medalie, et al.
Israel Journal of Medical Sciences
|
July 1, 1974
Diabetes mellitus among 10,000 adult men. I. Five-year incidence and associated variables
J H Medalie, C Papier, J B Herman, et al.
The Journal of Clinical Psychiatry
|
January 1, 1990
Fluoxetine-induced sexual dysfunction
J B Herman, A W Brotman, M H Pollack, et al.
Hospital & Community Psychiatry
|
March 1, 1991
Pilot outreach services to homebound agoraphobic patients
M H Pollack, G S Sachs, G E Tesar, et al.
Archives of General Psychiatry
|
May 1, 1988
Behavioral inhibition in children of parents with panic disorder and agoraphobia. A controlled study
J F Rosenbaum, J Biederman, M Gersten, et al.
The Journal of Clinical Psychiatry
|
February 1, 1991
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder
G E Tesar, J F Rosenbaum, M H Pollack, et al.
The Journal of Clinical Psychiatry
|
October 1, 1987
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial
G E Tesar, J F Rosenbaum, M H Pollack, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Psychopharmacology Bulletin
|
January 1, 1987
Clonazepam in the treatment of panic disorder and agoraphobia
M H Pollack, J F Rosenbaum, G E Tesar, et al.
Diabetes
|
December 1, 1970
Diabetes incidence: a two-year follow-up of 10,000 men in a survey of ischemic heart disease in Israel
J B Herman, J H Medalie, H A Kahn, et al.
Journal of Chronic Diseases
|
February 1, 1971
Factors related to diabetes incidence: a multivariate analysis of two years observation on 10,000 men. The Israel Ischemic Heart Disease Study
H A Kahn, J B Herman, J H Medalie, et al.
Israel Journal of Medical Sciences
|
July 1, 1974
Diabetes mellitus among 10,000 adult men. I. Five-year incidence and associated variables
J H Medalie, C Papier, J B Herman, et al.
The Journal of Clinical Psychiatry
|
January 1, 1990
Fluoxetine-induced sexual dysfunction
J B Herman, A W Brotman, M H Pollack, et al.
Hospital & Community Psychiatry
|
March 1, 1991
Pilot outreach services to homebound agoraphobic patients
M H Pollack, G S Sachs, G E Tesar, et al.
Archives of General Psychiatry
|
May 1, 1988
Behavioral inhibition in children of parents with panic disorder and agoraphobia. A controlled study
J F Rosenbaum, J Biederman, M Gersten, et al.
The Journal of Clinical Psychiatry
|
February 1, 1991
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder
G E Tesar, J F Rosenbaum, M H Pollack, et al.
The Journal of Clinical Psychiatry
|
October 1, 1987
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial
G E Tesar, J F Rosenbaum, M H Pollack, et al.
Page
of 3